Health Plans

Navigating Humira® & Stelara® Biosimilar Adoption Strategies

Worker

Impacted: Member Blues + Horizon ONLY

Biosimilars are creating new opportunities for health plans to improve affordability, manage specialty pharmacy costs and expand access to clinically appropriate therapies. As the market continues to evolve, organizations are evaluating how biosimilar adoption strategies can support both short-term savings and long-term pharmacy benefit goals. By exploring these resources, you can:

  • Understand key trends and developments shaping the evolving biosimilar marketplace.
  • Learn how organizations are evaluating Humira and Stelara biosimilar opportunities as part of future pharmacy benefit planning.
  • Explore formulary, adoption and operational considerations that can influence implementation strategies.
  • Assess the potential impact of biosimilars on affordability, specialty pharmacy trend management and member access.
  • Evaluate member experience considerations related to biosimilar adoption and coverage approaches.
  • Identify questions and decision points that can help inform savings opportunities and long-term affordability goals.

Available resources include:

  • Prime's Humira & Stelara Biosimilar Strategy Webcast Recording which explores the evolving biosimilar landscape, Prime's approach to Humira and Stelara biosimilar opportunities, and key formulary, operational and member experience considerations to support affordability and savings goals.
  • Prime's Humira & Stelara Biosimilar Strategy Overview Document featuring insights on market developments, adoption trends, savings opportunities, formulary considerations and questions to consider for future planning.

 

 

We value your feedback

Your feedback helps us shape future content and ensure we're providing timely, relevant insights on the topics that matter most to you. Whether you reviewed the resources, attended the webcast live or watched the recording, we encourage you to complete our brief feedback survey. Your input helps guide future discussions and resource development, enabling us to continue delivering insights and resources that support your organization's evolving pharmacy benefit strategy.